Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Neoprobe snags another Alseres exec
Neoprobe Corp. (NYSE:NEOP) named a new executive VP and chief business officer last week, former Alseres Pharmaceuticals Inc. (PINK:ALSE) molecular imaging president Dr. Thomas Tulip.
Tulip will seek out business opportunities for Neoprobe’s two radiopharmaceutical drug candidates and look for partner companies to form licensing agreements with, according to a statement.
This is the second poached Alseres executive, following Mark Pykett who stepped down as COO to become chief development officer at Neoprobe in November 2010.
- Kendle appoints a new VP, early stage
Kendle International Inc. (NSDQ:KNDL) named Dr. Pierre Geoffroy as early stage VP effective immediately. Geoffroy will oversee the development of global early stage programs from the company’s office in Toronto, Canada. Kendle just emerged from a $232 million acquisition by INC Research.
- N.C. Biotechnology Center’s western office gets new executive director
North Carolina Biotechnology Center named an executive director to oversee its western office. Dr. Jonathan Lawrie, a professor in the Center for Entrepreneurship and Innovation at Western Carolina University’s College of Business, will manage activities in the 25-country region. Lawrie takes the reins from Steve Casey, the Center’s VI of statewide operations, who has been serving as interim director for the last two years.
- Hansen Medical names new CFO
Hansen Medical Inc. (NSDQ:HNSN) announced the appointment of Peter Mariani as CFO, effective June 20. Mariani replaces Peter Osborne, who served as interim CEO of the Mountain View, Calif.-based catheter manipulation technology maker since February 2010.
- Bruker CFO steps down
Bruker Corp. (NSDQ:BRKR) announced that CFO Brian Monahan would step down from his position, becoming the company’s VP of strategic and financial planning. The move will grant Monahan more time with his young family, company officials said. Bruker’s current COO and former CFO William Knight will act as interim CFO until a permanent replacement is found.